BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35229728)

  • 1. Taking the STING out of acute myeloid leukemia through macrophage-mediated phagocytosis.
    Dalton WB; Ghiaur G; Resar LM
    J Clin Invest; 2022 Mar; 132(5):. PubMed ID: 35229728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LC3-associated phagocytosis in bone marrow macrophages suppresses acute myeloid leukemia progression through STING activation.
    Moore JA; Mistry JJ; Hellmich C; Horton RH; Wojtowicz EE; Jibril A; Jefferson M; Wileman T; Beraza N; Bowles KM; Rushworth SA
    J Clin Invest; 2022 Mar; 132(5):. PubMed ID: 34990402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tissue inhibitor of metalloproteinases-1 (TIMP-1) promotes survival and migration of acute myeloid leukemia cells through CD63/PI3K/Akt/p21 signaling.
    Forte D; Salvestrini V; Corradi G; Rossi L; Catani L; Lemoli RM; Cavo M; Curti A
    Oncotarget; 2017 Jan; 8(2):2261-2274. PubMed ID: 27903985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M2 macrophages drive leukemic transformation by imposing resistance to phagocytosis and improving mitochondrial metabolism.
    Weinhäuser I; Pereira-Martins DA; Almeida LY; Hilberink JR; Silveira DRA; Quek L; Ortiz C; Araujo CL; Bianco TM; Lucena-Araujo A; Mota JM; Hogeling SM; Sternadt D; Visser N; Diepstra A; Ammatuna E; Huls G; Rego EM; Schuringa JJ
    Sci Adv; 2023 Apr; 9(15):eadf8522. PubMed ID: 37058562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Put in a "Ca
    Lewuillon C; Laguillaumie MO; Quesnel B; Idziorek T; Touil Y; Lemonnier L
    Cells; 2022 Feb; 11(3):. PubMed ID: 35159351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bone marrow microenvironment - Home of the leukemic blasts.
    Shafat MS; Gnaneswaran B; Bowles KM; Rushworth SA
    Blood Rev; 2017 Sep; 31(5):277-286. PubMed ID: 28318761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute myeloid leukemia transforms the bone marrow niche into a leukemia-permissive microenvironment through exosome secretion.
    Kumar B; Garcia M; Weng L; Jung X; Murakami JL; Hu X; McDonald T; Lin A; Kumar AR; DiGiusto DL; Stein AS; Pullarkat VA; Hui SK; Carlesso N; Kuo YH; Bhatia R; Marcucci G; Chen CC
    Leukemia; 2018 Mar; 32(3):575-587. PubMed ID: 28816238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIGIT blockade repolarizes AML-associated TIGIT
    Brauneck F; Fischer B; Witt M; Muschhammer J; Oelrich J; da Costa Avelar PH; Tsoka S; Bullinger L; Seubert E; Smit DJ; Bokemeyer C; Ackermann C; Wellbrock J; Haag F; Fiedler W
    J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36549780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute myeloid leukemia induces protumoral p16INK4a-driven senescence in the bone marrow microenvironment.
    Abdul-Aziz AM; Sun Y; Hellmich C; Marlein CR; Mistry J; Forde E; Piddock RE; Shafat MS; Morfakis A; Mehta T; Di Palma F; Macaulay I; Ingham CJ; Haestier A; Collins A; Campisi J; Bowles KM; Rushworth SA
    Blood; 2019 Jan; 133(5):446-456. PubMed ID: 30401703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stromal cells derived from acute myeloid leukemia bone marrow exhibit aberrant cytogenetics and cytokine elaboration.
    Huang JC; Basu SK; Zhao X; Chien S; Fang M; Oehler VG; Appelbaum FR; Becker PS
    Blood Cancer J; 2015 Apr; 5(4):e302. PubMed ID: 25860293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Knockdown of let-7b in leukemia associated macrophages inhibit acute myeloid leukemia progression.
    Tian C; Li Y; Si J; Kang J; Chen Z; Nuermaimaiti R; Wang Y; Yu Y; Zhao Z; Wang X; Zhang Y; Zhao H; Yang H; You MJ; Zheng G; Wang L
    Hematol Oncol; 2023 Aug; 41(3):510-519. PubMed ID: 36579468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYLD stimulates macrophage phagocytosis of leukemic cells through STAT1 signalling in acute myeloid leukemia.
    Huyen NT; Ngoc NT; Giang NH; Trang DT; Hanh HH; Binh VD; Giang NV; Canh NX; Xuan NT
    PLoS One; 2023; 18(8):e0283586. PubMed ID: 37549179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LC3-Associated Phagocytosis in Myeloid Cells Promotes Tumor Immune Tolerance.
    Cunha LD; Yang M; Carter R; Guy C; Harris L; Crawford JC; Quarato G; Boada-Romero E; Kalkavan H; Johnson MDL; Natarajan S; Turnis ME; Finkelstein D; Opferman JT; Gawad C; Green DR
    Cell; 2018 Oct; 175(2):429-441.e16. PubMed ID: 30245008
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIF1α drives chemokine factor pro-tumoral signaling pathways in acute myeloid leukemia.
    Abdul-Aziz AM; Shafat MS; Sun Y; Marlein CR; Piddock RE; Robinson SD; Edwards DR; Zhou Z; Collins A; Bowles KM; Rushworth SA
    Oncogene; 2018 May; 37(20):2676-2686. PubMed ID: 29487418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways.
    Bakhtiyari M; Liaghat M; Aziziyan F; Shapourian H; Yahyazadeh S; Alipour M; Shahveh S; Maleki-Sheikhabadi F; Halimi H; Forghaniesfidvajani R; Zalpoor H; Nabi-Afjadi M; Pornour M
    Cell Commun Signal; 2023 Sep; 21(1):252. PubMed ID: 37735675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alteration Analysis of Bone Marrow Mesenchymal Stromal Cells from De Novo Acute Myeloid Leukemia Patients at Diagnosis.
    Desbourdes L; Javary J; Charbonnier T; Ishac N; Bourgeais J; Iltis A; Chomel JC; Turhan A; Guilloton F; Tarte K; Demattei MV; Ducrocq E; Rouleux-Bonnin F; Gyan E; Hérault O; Domenech J
    Stem Cells Dev; 2017 May; 26(10):709-722. PubMed ID: 28394200
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor Microenvironment in Acute Myeloid Leukemia: Adjusting Niches.
    Menter T; Tzankov A
    Front Immunol; 2022; 13():811144. PubMed ID: 35273598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogeneous effects of M-CSF isoforms on the progression of MLL-AF9 leukemia.
    Wang R; Feng W; Yang F; Yang X; Wang L; Chen C; Hu Y; Ren Q; Zheng G
    Immunol Cell Biol; 2018 Feb; 96(2):190-203. PubMed ID: 29363207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PI3K inhibitor GDC-0941 enhances apoptotic effects of BH-3 mimetic ABT-737 in AML cells in the hypoxic bone marrow microenvironment.
    Jin L; Tabe Y; Kojima K; Shikami M; Benito J; Ruvolo V; Wang RY; McQueen T; Ciurea SO; Miida T; Andreeff M; Konopleva M
    J Mol Med (Berl); 2013 Dec; 91(12):1383-97. PubMed ID: 23955073
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypoxia-CXCL6 axis affects arteriolar niche remodeling in acute myeloid leukemia.
    Li L; Man J; Zhao L
    Exp Biol Med (Maywood); 2021 Jan; 246(1):84-96. PubMed ID: 33167688
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.